The Healthon Weight Loss Program offers two highly effective GLP-1 medications: Semaglutide (Generic Ozempic/Wegovy): A GLP-1 receptor agonist, FDA-approved for weight management and type 2 diabetes
Its not available in Alaska, Alabama, Arkansas, DC, Delaware, Kansas, Louisiana, Mississippi, North Dakota, New Mexico, Rhode Island, South Dakota, Vermont, West Virginia, or Wyoming
Final Thoughts GLP-1 medications offer remarkable benefits beyond just helping with weight loss and diabetes
While GIP has lost most of its insulinotropic activity in patients with T2D, GLP-1 has retained enough of its insulinotropic activity to stimulate insulin secretory responses even in patients with T2D [55]
IPTW, inverse probability of treatment weighting